|
|
Sangamo Biosciences, Inc. - Comparative Business Analysis Snapshot
Business Description
Sangamo Biosciences, Inc.. The Group's principal activities are researching, developing and commercializing engineered zinc finger DNA binding proteins for regulation of gene expression and gene modification. The Group has developed a proprietary technology platform enabling the engineering of a class of transcription factors known as Zinc finger DNA-binding proteins (ZFPs). The engineered ZFPs are applicable in pharmaceutical discovery, development of human therapeutics, clinical diagnostics and plant agricultural and biotechnology industry. It operates in the United States.
Competitor Analysis
This analysis compares Sangamo Biosciences, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
